Antitope Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Antitope Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3389
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The company’s iTope technology is used to identify peptides; and T cell epitope database is used for screening amino acid sequences from antibodies or proteins. Its epiScreen T cell epitope mapping identifies the exact number and location of T cell epitopes within an antibody or protein. Antitope’s technologies are used in the immunogenicity assessment and protein engineering to develop humanized antibodies and deimmunised proteins. The company also provides services and technologies for the selection, development and manufacturing of biopharmaceuticals based on antibodies and other proteins. Antitope is headquartered in Cambridge, Cambridgeshire, the UK.

Antitope Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antitope Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Antitope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Antitope Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 10
Antitope Enters Into Research Agreement With Annexon For Therapeutic Antibodies 12
Antitope Enters Into Research Agreement With ChemomAb For Composite Human Antibodies 13
Antitope Enters Into Co-Development Agreement With Research Corporation Technologies For Therapeutic Protein 14
Antitope Enters Into Co-Development Agreement With Eden Biodesign For Therapeutic Antibodies 15
Antitope Enters Into Research Agreement With NeuroPhage Pharma 16
Licensing Agreements 17
ProtAb Enters into License Agreement with Antitope 17
Antitope Enters into Licensing Agreement with University College London for Humanized Antibodies 18
Acquisition 19
PolyTherics Acquires Antitope For US$20.7 Million 19
Antitope Ltd – Key Competitors 20
Antitope Ltd – Key Employees 21
Antitope Ltd – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Antitope Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antitope Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antitope Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Antitope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 10
Antitope Enters Into Research Agreement With Annexon For Therapeutic Antibodies 12
Antitope Enters Into Research Agreement With ChemomAb For Composite Human Antibodies 13
Antitope Enters Into Co-Development Agreement With Research Corporation Technologies For Therapeutic Protein 14
Antitope Enters Into Co-Development Agreement With Eden Biodesign For Therapeutic Antibodies 15
Antitope Enters Into Research Agreement With NeuroPhage Pharma 16
ProtAb Enters into License Agreement with Antitope 17
Antitope Enters into Licensing Agreement with University College London for Humanized Antibodies 18
PolyTherics Acquires Antitope For US$20.7 Million 19
Antitope Ltd, Key Competitors 20
Antitope Ltd, Key Employees 21

List of Figures
Antitope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Antitope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Antitope Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Antitope Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Credit Suisse (UK) Private Banking:企業の戦略・SWOT・財務情報
    Credit Suisse (UK) Private Banking - Strategy, SWOT and Corporate Finance Report Summary Credit Suisse (UK) Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Hengeler Mueller Partnerschaft von Rechtsanwalten mbB:企業の戦略的SWOT分析
    Hengeler Mueller Partnerschaft von Rechtsanwalten mbB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key com …
  • Broadspectrum (Australia) Pty Ltd:企業の戦略的SWOT分析
    Broadspectrum (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Gannett Co., Inc.
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Albireo Pharma Inc (ALBO):企業の財務・戦略的SWOT分析
    Albireo Pharma Inc (ALBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Contact Energy Ltd (CEN):企業の財務・戦略的SWOT分析
    Contact Energy Ltd (CEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PJSC Detsky Mir (DSKY):企業の財務・戦略的SWOT分析
    PJSC Detsky Mir (DSKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報
    Summary Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, p …
  • AngloGold Ashanti Limited:戦略・SWOT・企業財務分析
    AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report Summary AngloGold Ashanti Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Kentucky Power Co:発電所・企業SWOT分析
    Kentucky Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Paul Hastings LLP:企業の戦略的SWOT分析
    Paul Hastings LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • GridPoints Inc:企業の戦略的SWOT分析
    GridPoints Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Primark Stores Ltd:企業の戦略・SWOT・財務情報
    Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hill’s Pet Nutrition, Inc.:企業の戦略的SWOT分析
    Hill's Pet Nutrition, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Continental AG:企業の戦略・SWOT・財務分析
    Continental AG - Strategy, SWOT and Corporate Finance Report Summary Continental AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Broadwind Energy, Inc. (BWEN)-エネルギー分野:企業M&A・提携分析
    Summary Broadwind Energy, Inc. (Broadwind) is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. It offers a wide range of products from gears and gearing systems, to wind turbine towers, fabrications and industrial weldments. B …
  • Interseguro Compania de Seguros SA:企業の戦略・SWOT・財務分析
    Interseguro Compania de Seguros SA - Strategy, SWOT and Corporate Finance Report Summary Interseguro Compania de Seguros SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Laboratoire HRA Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoire HRA Pharma (HRA Pharma) is a healthcare products provider that offers women’s health and endocrinology products. The company offers a wide range of women’s health products which include emergency contraception, uterine fibroids, regular contraception and genital herp products amo …
  • GSS Infotech Limited (GSS):企業の財務・戦略的SWOT分析
    GSS Infotech Limited (GSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TIBCO Software Inc:企業の戦略的SWOT分析
    TIBCO Software Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆